Renal Artery Calcium and Hypertension

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2006 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00388869
First received: October 15, 2006
Last updated: October 16, 2006
Last verified: October 2006
  Purpose

CT of the abdomen is a very common examination performed for various indications.One of the common findings is vascular calcifications including calcifications of the renal arteries.Calcifications in the carotid arteries and coronary arteries are good predictor for obstructive atherosclerotic disease.Stenosis of the renal arteries can cause symptomatic or asymptomatic hypertension with subsequent clinical sequelae. Therefore early diagnosis of this condition is imperative.

The goal of our study is to investigate the correlation between incidental calcifications of the renal arteries in CT examinations and the presence of actual stenosis of these vessels in patients with and without hypertension.


Condition
Hypertension
Atherosclerosis

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Official Title: Calcifications of the Renal Arteries and Renal Artery Stenosis in Patients With and Without Hypertension?

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

Estimated Enrollment: 300
Study Start Date: November 2006
Detailed Description:

Every patient aged 30-100 referred for abdominal CT examination with IV contrast injection will be included in this study (total 300 patients.Prior to the examination relevant clinical data including history of hypertension and predisposing conditions for atherosclerotic disease, will be investigated. The patient will undergo conventional CT with no special procedures. The images will be review by the radiologist for the presence of renal arteries calcifications, renal arteries stenosis,plaque location, plaque burden and characterization and secondary renal pathology.

This study will not change the examination technique and is not associated with any inconvenience to the patients.

  Eligibility

Ages Eligible for Study:   30 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Every patient referred fo abdominal CT aged 30-100

Exclusion Criteria:

  • Contraindication for IV contrast injection failure to demonstrate renal arteries with contrast refusal to sign an informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00388869

Contacts
Contact: Nurith Hiller, MD 972-50-7874980 hiller@netvision.net.il

Locations
Israel
Hadassah Medical Organization Not yet recruiting
Jerusalem, Israel
Contact: Arik Tzukert, DMD    00-972-2-6776095    arik@hadassah.org.il   
Contact: Hadas Lemberg, phD    00-972-2-6777572    lhadas@hadassah.org.il   
Principal Investigator: Nurith Hiller, MD         
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: Nurith Hiller, MD Hadassah Medical Organization
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00388869     History of Changes
Other Study ID Numbers: HILLER-HMO-CTIL
Study First Received: October 15, 2006
Last Updated: October 16, 2006
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Hadassah Medical Organization:
renal artery
calcium
CT
hypertension

Additional relevant MeSH terms:
Arteriosclerosis
Atherosclerosis
Hypertension
Arterial Occlusive Diseases
Cardiovascular Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on October 23, 2014